Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]

Cancer medicine shortages for children around the world

Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis...

Cancer medicine shortages for children around the world ( Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA )

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL

Dr Ibrahim Aldoss - City of Hope, Duarte, USA

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL ( Dr Ibrahim Aldoss - City of Hope, Duarte, USA )

Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory...

Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA

$Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large B-cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )$

Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared...

Dr Martin Kaiser - The Institute of Cancer Research, London UK

Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared with myeloma XI/XI+ Trial treatment for Uhir MM ( Dr Martin Kaiser - The Institute of Cancer Research, London UK )

Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted...

Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA

Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted consolidation therapy gives highest rate of MRD negativity in NDMM ( Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA )

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative...

Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients ( Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA )

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in...

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA

$Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )$

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma

Prof Elizabeth Budde - City of Hope, Duarte, USA

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma ( Prof Elizabeth Budde - City of Hope, Duarte, USA )

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )

Safety profile of BiTE therapy

Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany

Anti-CD38 immunotherapy treatment for multiple myeloma

Prof Xavier Leleu - CHU de Poitiers, Poitiers, France

Anti-CD38 immunotherapy treatment for multiple myeloma ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )

Paediatric ALL perspective

Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy

Paediatric ALL perspective ( Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy )

More from ecancer